Evidence map›Paper›PMID 41423667›Full record

ArticleScientific reports2025

Research on cross-dataset cardiac signal domain generalization and feature interpretability.

Runwen Li, Yierpani Aierken, Yu Xu, Jiang Liu, Yongjiang Tang

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Runwen Li *Department of Vascular Diseases, Panzhihua Central Hospital, Panzhihua, 617000, China. RunwenLi@outlook.com.
Yierpani Aierken *Department of Vascular Surgery, Tianjin Medical University General Hospital, Tianjin, 300052, China.
Yu XuDepartment of Cardiovascular Surgery, Fujian Medical University Union Hospital, Fuzhou, China.
Jiang LiuDepartment of Vascular Diseases, Panzhihua Central Hospital, Panzhihua, 617000, China.
Yongjiang Tang *Department of Vascular Diseases, Panzhihua Central Hospital, Panzhihua, 617000, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cross-dataset modeling of electrocardiogram signals faces the dual challenges of domain shift and insufficient interpretability in clinical applications. To address these issues, this study proposes a Transformer-based cross-domain ECG modeling framework that incorporates a Domain-invariant Feature Enhancement Module and an Interpretability-driven Attention Constraint Mechanism, aiming to simultaneously improve cross-domain generalization and clinical interpretability. Experiments on four authoritative arrhythmia databases (MIT-BIH Supraventricular, MIT-BIH Arrhythmia, INCART, and SCD-Holter) demonstrate that the proposed method achieves the best performance across all target domains, with accuracy on the MIT-BIH Arrhythmia dataset reaching 0.768 (an improvement of 8.4% over the baseline Transformer) and F1-score on the INCART dataset attaining 0.898 (a gain of 4.7% compared with the second-best method). In addition, ablation studies verify the complementary contributions of DFEM and IACM, while feature importance analysis and t-SNE visualization further confirm that the model consistently attends to clinically relevant features. These results indicate that the proposed framework can effectively mitigate domain shift without relying on target-domain samples, while enhancing interpretability alongside discriminative performance.

Indexed as

Arrhythmias, CardiacElectrocardiographySignal Processing, Computer-AssistedAlgorithmsDatabases, FactualHumansDeep learningDomain generalizationECG SignalInterpretability

Identifiers

PMID41423667
PMCPMC12830862

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.